Effective preclinical drug development hinges on the deployment of robust in vivo models that accurately recapitulate human disease and response to therapy. Optimizing these models involves a multifaceted approach, https://nicolasiwqj006598.blog-gold.com/40984377/optimizing-in-vivo-models-for-preclinical-drug-development